Nelly Robillard
Overview
Explore the profile of Nelly Robillard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1059
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Letestu R, Dahmani A, Boubaya M, Baseggio L, Campos L, Chatelain B, et al.
Leukemia
. 2020 Sep;
35(6):1597-1609.
PMID: 32934355
Measurable residual disease (MRD) status is widely adopted in clinical trials in patients with chronic lymphocytic leukemia (CLL). Findings from FILO group trials (CLL2007FMP, CLL2007SA, CLL2010FMP) enabled investigation of the...
2.
Debord C, Bourcier J, Subiger F, Leclair F, Touzeau C, Gastinne T, et al.
Ann Hematol
. 2020 Mar;
100(1):285-287.
PMID: 32193629
No abstract available.
3.
Solly F, Angelot-Delettre F, Ticchioni M, Genevieve F, Rambaud H, Baseggio L, et al.
Cytometry A
. 2019 Aug;
95(9):1008-1018.
PMID: 31364809
Flow cytometry is broadly used for the identification, characterization, and monitoring of hematological malignancies. However, the use of clinical flow cytometry is restricted by its lack of reproducibility across multiple...
4.
Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, et al.
Cytokine
. 2019 Apr;
120:85-87.
PMID: 31035172
Objective: This study was designed to assess the impact on outcomes of early soluble Fms-like tyrosine kinase 3 ligand concentrations (sFLc) in patients receiving an allogeneic hematopoietic stem cell transplantation...
5.
Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, et al.
Haematologica
. 2019 Jan;
104(6):e240-e243.
PMID: 30630980
No abstract available.
6.
Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien M, et al.
Blood
. 2018 Sep;
132(23):2456-2464.
PMID: 30249784
The introduction of novel agents has led to major improvements in clinical outcomes for patients with multiple myeloma. To shorten evaluation times for new treatments, health agencies are currently examining...
7.
Debord C, Robillard N, Theisen O, Gastinne T, Godmer P, Graveleau J, et al.
Hematol Oncol
. 2018 Apr;
PMID: 29656538
No abstract available.
8.
Boutault R, Le Glaunec J, Debord C, Robillard N, Nicolet L, Eveillard M
Br J Haematol
. 2018 Feb;
180(4):471.
PMID: 29388203
No abstract available.
9.
Chevallier P, Chantepie S, Huguet F, Raffoux E, Thomas X, Leguay T, et al.
Haematologica
. 2017 Feb;
102(5):e184-e186.
PMID: 28154086
No abstract available.
10.
Boisseau P, Bene M, Besnard T, Pachchek S, Giraud M, Talarmain P, et al.
Br J Haematol
. 2016 Nov;
180(5):750-752.
PMID: 27879994
No abstract available.